Hussman Strategic Advisors, Inc. Biocept Inc Transaction History

Hussman Strategic Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 01, 2021	SELL	$3.39 - $4.34 $244,080 - $312,480	-72,000 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$4.74 - $7.94 $324,690 - $543,890	68,500 Added 1957.14%	72,000 $366,000
Q4 2020 Feb 01, 2021	SELL	$4.31 - $6.16 $344,799 - $492,800	-80,000 Reduced 95.81%	3,500 $16,000
Q3 2020 Nov 02, 2020	BUY	$3.61 - $11.4 $301,435 - $951,900	83,500 New	83,500 $368,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.